Congenital adrenal hyperplasia with 11β-hydroxylase deficiency

Journal of the Formosan Medical Association

Volumn 103, Issue 11, 2004, Pages 860-864

  Chang, Shu Hua ^a   Lee, Hsien Hsiung ^b   Wang, Pen Jung ^a   Chen, Jui Hsia ^a   Chu, Shao Yin ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b King Car Food Industrial Co Ltd   (Taiwan)

Author keywords

Congenital adrenal hyperplasia; Point mutation; Steroid 11 beta hydroxylase; Taiwan

Indexed keywords

CORTISONE ACETATE; CORTODOXONE; DEOXYCORTICOSTERONE; DEXAMETHASONE; DNA; FLUDROCORTISONE; HYDROCORTISONE; HYDROXYPROGESTERONE; LEUCINE; LOOP DIURETIC AGENT; POTASSIUM; PROLINE; STEROID 11BETA MONOOXYGENASE; STEROID 21 MONOOXYGENASE;

ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; CASE REPORT; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; DIAGNOSTIC ERROR; DRUG WITHDRAWAL; ENZYME DEFICIENCY; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOKALEMIA; NUCLEOTIDE SEQUENCE; POINT MUTATION; SCHOOL CHILD; SEIZURE; STEROID 21 MONOOXYGENASE DEFICIENCY; TREATMENT OUTCOME;

ADRENAL HYPERPLASIA, CONGENITAL; CHILD; DIAGNOSTIC ERRORS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; POINT MUTATION; STEROID 11-BETA-HYDROXYLASE;

EID: 12344315832     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. White PC, Speiser PW: Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am 1994; 23:325-39.
2. White PC: Steroid 11-beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am 2001;30:61-79.
3. Nicholson JF, Pesce MA: Reference ranges for laboratory tests and procedures. in: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: Saunders; 2000:2181-229.
4. Merke DP, Tajima T, Chhabra A, et al: Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11β-hydroxylase deficiency. J Clin Endocrinol Metab 1998;83:270-3.
5. Al-Jurayyan N: Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency in Saudi Arabia: clinical and biochemical characteristics. Acta Pediatr 1995;84:651-4.
6. Chabre O, Portrat-Doyen S, Chaffanjon P, et al: Bilateral laparoscopic adrenectomy for congenital adrenal hyperplasia with severe hypertension: resulting from two novel mutations in splice donor sites of CYP11B1. J Clin Endocr Metab 2000;85: 4060-8.
7. Rosler A, Leiberman E, Sack J, et al: Clinical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Hormone Res 1982;16:133-41.
8. Hochberg Z, Schechter J, Benderly A, et al: Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11-β-hydroxylase deficiency. AJDC 1985;139: 771-6.
9. Rivkees S, Crawford J. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 2000;106:767-73.
10. Chaudhri O, Goodlad C, Hameed A, et al: Congenital adrenal hyperplasia: A tale of two enzymes [abstract]. 21st Joint Meeting of the British Endocrine Societies, April 2002;3:25.
11. Chu SY, Tsai WY, Chen LH, et al: Neonatal screening for congenital adrenal hyperplasia in Taiwan: A pilot study. J Formos Med Assoc 2002;101:691-4.